Together, our data support a model in which PAQR8 promotes breast cancer recurrence by facilitating resistance to multiple antineoplastic therapies in a manner that alters ceramide levels and requires coupling to a Gi protein. This evidence concerns the gene PAQR8 and breast cancer.